Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Use of 3-hydroxy-3-methylgutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy

US Patent 6894058 · Granted May 17, 2005

Estimated economic value: $16,191,000

Assignee

Inventors

View full patent text on Google Patents →